• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3851
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 09/06/2023
Event Type  Injury  
Event Description
It was reported that a dissection occurred.The patient presented for a percutaneous transluminal coronary angioplasty (ptca).The 90% stenosed lesion was located in a mildly tortuous and moderately calcified mid eft anterior descending artery (lad).The lesion was not pre-dilated with 2.50 x 12 mm non-complaint balloon.The target lesion was fibrotic, hence a 3.00 x 10 wolverine balloon used for the vessel preparation.A 3.00 x 10 wolverine balloon used to dilate the lesion at 12 atmospheres from left main (lm) to mid lad.Then, a 3.50 x 20 mm synergy stent tried to deploy the stent, but the catheter failed cross the distal lesion.The device removed with the stent from the patient, and it was noted the stent strut damaged.Then, the lesion was dilated with wolverine balloon at 18 atmospheres for two to three cycles in preferential method.Since, imaging was not there, the physician assumed that a distal mild dissection occurred.The procedure was completed with 3.50 x 24 mm synergy stent.A 4.00 x 8.00 mm non-complaint balloon was used to post dilate the lm.There were no further patient complications reported.Post procedure, the patient was safe.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17827672
MDR Text Key324396602
Report Number2124215-2023-52077
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 09/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number3851
Device Catalogue Number3851
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexMale
Patient RaceAsian
-
-